Conjugated (Direct) Hyperbilirubinemia

Conjugated (Direct) Hyperbilirubinemia is a condition where there is an excess of a specific type of bilirubin in the blood that has already been processed by the liver. This condition affects the liver and bile system, which are responsible for breaking down old red blood cells and removing waste. When the liver or bile ducts are damaged or blocked, the processed bilirubin cannot be properly excreted and builds up in the body. This buildup can cause yellowing of the skin and eyes (jaundice), dark urine, and pale stools. It may also indicate underlying problems such as liver disease or bile duct obstruction, which can affect overall health and digestion.

Conjugated (Direct) Hyperbilirubinemia is defined as an elevation of conjugated bilirubin in the serum, typically greater than 20% of the total bilirubin or above 0.3 mg/dL. It results from impaired hepatic excretion of bilirubin due to hepatocellular injury, cholestasis, or biliary obstruction. The core pathology involves disruption of bilirubin transport from hepatocytes into bile canaliculi or obstruction of bile flow. Common causes include hepatitis, cirrhosis, biliary atresia, gallstones, and tumors obstructing bile ducts. This condition is clinically significant because it indicates liver dysfunction or biliary obstruction, which can lead to complications such as cholestatic liver injury and progressive liver failure if untreated. It is distinguished from unconjugated hyperbilirubinemia by the presence of water-soluble bilirubin that is excreted in urine, causing dark urine.